Strategies in the Battle against Recurrent UTIs: A Brief Overview

Year : 2024 | Volume : 14 | Issue : 03 | Page : 68 73
    By

    Adinarayana Andy,

  • Divya Andy,

  • Aman Suresh Tharayil,

  • N V L Sirisha Mulukuri,

  1. Pharmacy Manager, Weatherwax Family Pharmacies Inc Spring Arbor, Michigan, USA
  2. Independent Research, Consultant, Michigan, USA
  3. Assistant Professor, Department of Pharmacy Practice, Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India
  4. Associate Professor, Nitte College of Pharmaceutical Sciences, Bangalore, India

Abstract

Recurrent urinary tract infections (UTIs) present a serious medical issue, and such conditions can disappoint those affected. They are uncomfortable, but a difficulty arises because treating such conditions with antibiotics comes with the risk of antibiotic overuse. This summary will evaluate the measures incorporated in treating frequent UTIs in the contemporary world. These measures include taking antibiotics regularly to prevent infections and alternatives to antibiotics such as probiotics, cranberry extract, and D-mannose. Changes in lifestyle and behavior, such as drinking more fluids and practicing better hygiene etiquette, also help decrease the chances of repeated UTIs. There is also promising progress on the UTI vaccines and possibilities of individual-based medicine in treatment approaches improvement in the future. With these and other methods, it should be possible to curb the chances of reinfection while minimizing the use of antibiotics in the treatment, which is a beneficial strategy considering the issue of global antibiotic resistance.

Keywords: D-mannose, behavioral interventions, UTI vaccines, precision medicine, antibiotic resistance.

[This article belongs to Research & Reviews: A Journal of Pharmacology ]

How to cite this article:
Adinarayana Andy, Divya Andy, Aman Suresh Tharayil, N V L Sirisha Mulukuri. Strategies in the Battle against Recurrent UTIs: A Brief Overview. Research & Reviews: A Journal of Pharmacology. 2024; 14(03):68-73.
How to cite this URL:
Adinarayana Andy, Divya Andy, Aman Suresh Tharayil, N V L Sirisha Mulukuri. Strategies in the Battle against Recurrent UTIs: A Brief Overview. Research & Reviews: A Journal of Pharmacology. 2024; 14(03):68-73. Available from: https://journals.stmjournals.com/rrjop/article=2024/view=189849


Browse Figures

References

  1. Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary tract infections: the current scenario and prospects. Pathogens. 2023;12(4):623.
  2. Santos M, Mariz M, Tiago I, Martins J, Alarico S, Ferreira P. A review on urinary tract infections diagnostic methods: Laboratory-based and point-of-care approaches. J Pharm Biomed Anal. 2022;219:114889, https://doi.org/10.1016/j.jpba.2022.114889.
  3. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84.
  4. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011 Mar 1;52(5):e103-20. doi: 10.1093/cid/ciq257.
  5. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182(4):1177-82.
  6. Ventola CL. The antibiotic resistance crisis: Part 1: Causes and threats. P T. 2015;40(4):277-83.
  7. Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: A randomized clinical trial. World J Urol. 2014;32(1):79-84.
  8. Porru D, Parmigiani A, Tinelli C, Barletta D, Choussos D, Tudino D, et al. Oral D-mannose in recurrent urinary tract infections. Urol Int. 2010;84(4):450-4.
  9. Wang CH, Fang CC, Chen NC, Liu SS, Yu PH, Wu TY, et al. Cranberry-containing products for prevention of urinary tract infections: A meta-analysis. Arch Intern Med. 2012;172(13):988-96.
  10. Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2016;(7).
  11. Wagenlehner FM, Ballarini S, Pilatz A, Weidner W. Immunoactive prophylaxis of recurrent urinary tract infections: A meta-analysis. Int J Antimicrob Agents. 2011;38(2):102-10.
  12. Barrons R, Tassone C. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: A review. Clin Ther. 2008;30(3):453-68.
Regular Issue Subscription Review Article
Volume 14
Issue 03
Received 01/11/2024
Accepted 27/11/2024
Published 17/12/2024
268

Login


My IP

PlumX Metrics